Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Apothecary is a specialized compounding pharmacy and healthcare provider that has focused on personalized medicine since its founding in 1994. The company is a leader in the clinical application of Low Dose Naltrexone (LDN) for autoimmune and chronic pain conditions, as well as Bioidentical Hormone Replacement Therapy (BHRT) for men and women. Operating out of a state-of-the-art facility in Sartell, Minnesota, The Apothecary provides custom-tailored sterile and non-sterile medications, nutritional consultations, and professional-grade supplements. The business model emphasizes a patient-centered approach, working closely with practitioners to address root causes of illness through individualized therapeutic interventions. Their services cater to a broad range of therapeutic areas, including endocrinology, immunology, and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Apothecary.